Method for treating coumarin-induced hemorrhage

Details Method for treating coumarin-induced hemorrhage Method for treating coumarin-induced hemorrhage

2006-10-03

2006-10-03

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S381000

Reexamination Certificate

active

07115559

ABSTRACT:
Use of factor XIII for treating coumarin-induced hemorrhage or bleeding. The coumarin may be warfarin or dicoumarol. A patient having coumarin-induced bleeding is treated with factor XIII alone or in conjunction with vitamin K.

REFERENCES:
patent: 3458287 (1969-07-01), Gross et al.
patent: 3931399 (1976-01-01), Bohn et al.
patent: 4503039 (1985-03-01), Kotitschke et al.
patent: 4525341 (1985-06-01), Deihl
patent: 4627879 (1986-12-01), Rose et al.
patent: 5610147 (1997-03-01), Seelich
patent: 5612456 (1997-03-01), Bishop et al.
patent: 5710174 (1998-01-01), West et al.
File HCAPLUS on STN, DN No. 116:15565. Uemura et al. ‘Basic Research for Hemostatic Agen, ‘GTXIII’. Study for Hemostatic and Thromgenic Ability in in Vivo.’ Sitai Zairyo (1991), 9(2), 56-63. Abstract Only, Abstract date Jan. 1992.

Affiliated with

Also associated with

Rating

Method for treating coumarin-induced hemorrhage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating coumarin-induced hemorrhage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating coumarin-induced hemorrhage will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3694794